W. Egan

发表

Guiding molecules towards drug-likeness.

M. Murcko, W. P. Walters, W. Egan, 2002, Current opinion in drug discovery & development.

A statistical-based approach to assessing the fidelity of combinatorial libraries encoded with electrophoric molecular tags. Development and application of tag decode-assisted single bead LC/MS analysis.

W. Egan, J. Reader, M. Orlowski, 2000, Journal of combinatorial chemistry.

Prediction of drug absorption using multivariate statistics.

J J Baldwin, K. Merz, W. Egan, 2000, Journal of medicinal chemistry.

Should Cardiosafety be Ruled by hERG Inhibition? Early Testing Scenarios and Integrated Risk Assessment

S. Whitebread, W. Egan, Q. Lu, 2009 .

In silico prediction of drug safety: despite progress there is abundant room for improvement.

G. Zlokarnik, W. Egan, P. Grootenhuis, 2004, Drug discovery today. Technologies.

2 - Combinatorial Chemistry and High-Throughput Screening in Drug Discovery and Development

John J. Baldwin, W. Egan, J. Baldwin, 2001 .

Drug Design: Predicting ADME properties in drug discovery

W. Egan, 2010 .

Chapter 29 Computational Models for ADME

William Egan, W. Egan, 2007 .

A method for estimating the risk of drug-induced phototoxicity and its application to smoothened inhibitors

William Egan, W. Egan, B. Lagu, 2011 .

Prediction of intestinal permeability.

William J Egan, Georgio Lauri, W. Egan, 2002, Advanced drug delivery reviews.

Can we use docking and scoring for hit-to-lead optimization?

Istvan J. Enyedy, William J. Egan, W. Egan, 2008, J. Comput. Aided Mol. Des..

Computation of the physio‐chemical properties and data mining of large molecular collections

Kenneth M. Merz, Steven L. Dixon, Ailan Cheng, 2002, J. Comput. Chem..

Can we use docking and scoring for hit-to-lead optimization?

W. Egan, I. Enyedy, 2008, J. Comput. Aided Mol. Des..

Drug Design: Predicting ADME properties in drug discovery

W. Egan, 2010 .